top of page

Mammoth Biosciences' Trevor Martin on using ultra-compact CRISPR systems to go after extra-hepatic indications in-vivo

Trevor Martin describes how Mammoth is working on the evolution of CRISPR to help make it more versatile for potential use in broad in-vivo applications.




Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page